Sepsis biomarkers: past, present and future
- 2 February 2019
- journal article
- editorial
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 57 (9) , 1281-1283
Abstract
Article Sepsis biomarkers: past, present and future was published on September 1, 2019 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 57, issue 9).Keywords
This publication has 17 references indexed in Scilit:
- Procalcitonin-guided antibiotic therapy: an expert consensusClinical Chemistry and Laboratory Medicine (CCLM), 2018
- Prognostic value of presepsin in adult patients with sepsis: Systematic review and meta-analysisPLOS ONE, 2018
- Diagnostic and prognostic value of presepsin vs. established biomarkers in critically ill patients with sepsis or systemic inflammatory response syndromeClinical Chemistry and Laboratory Medicine (CCLM), 2017
- Incidence and Trends of Sepsis in US Hospitals Using Clinical vs Claims Data, 2009-2014JAMA, 2017
- SIRS, qSOFA and new sepsis definitionJournal of Thoracic Disease, 2017
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Integration of Diagnostic Microbiology in a Model of Total Laboratory AutomationLaboratory Medicine, 2015
- ICU mortality rates in patients with sepsis compared with patients without sepsisCritical Care, 2015
- Epidemiology of severe sepsisVirulence, 2013
- Current and Projected Workforce Requirements for Care of the Critically Ill and Patients With Pulmonary DiseaseCan We Meet the Requirements of an Aging Population?JAMA, 2000